Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases

被引:24
|
作者
Wright, Gareth S. A. [1 ]
Watanabe, Tatiana F. [1 ]
Amporndanai, Kangsa [1 ]
Plotkin, Steven S. [2 ]
Cashman, Neil R. [3 ]
Antonyuk, Svetlana V. [1 ]
Hasnain, S. Samar [1 ]
机构
[1] Fac Hlth & Life Sci, Inst Syst Mol & Integrat Biol, Dept Biochem & Syst Biol, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England
[2] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada
[3] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 2B5, Canada
基金
英国生物技术与生命科学研究理事会;
关键词
PROTEIN; 43; TDP-43; N-TERMINAL DOMAIN; PHASE-SEPARATION; BINDING; RECOGNITION; STABILITY; SCLEROSIS; DYNAMICS; FOLD;
D O I
10.1016/j.isci.2020.101159
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mislocalization, cleavage, and aggregation of the human protein TDP-43 is found in many neurodegenerative diseases. As is the case with many other proteins that are completely or partially structurally disordered, production of full-length recombinant TDP-43 in the quantities necessary for structural characterization has proved difficult. We show that the full-length TDP-43 protein and two truncated N-terminal constructs 1-270 and 1-263 can be heterologously expressed in E. coli. Full-length TDP-43 could be prevented from aggregation during purification using a detergent. Crystals grown from an N-terminal construct (1-270) revealed only the N-terminal domain (residues 1-80) with molecules arranged as parallel spirals with neighboring molecules arranged in head-to-tail fashion. To obtain detergent-free, full-length TDP-43 we mutated all six tryptophan residues to alanine. This provided sufficient soluble protein to collect small-angle X-ray scattering data. Refining relative positions of individual domains and intrinsically disordered regions against this data yielded a model of full-length TDP-43.
引用
收藏
页数:22
相关论文
共 50 条
  • [11] Structural characterization of the minimal segment of TDP-43 competent for aggregation
    Mompean, Miguel
    Buratti, Emanuele
    Guarnaccia, Corrado
    Brito, Rui M. M.
    Chakrabartty, Avijit
    Baralle, Francisco E.
    Laurents, Douglas V.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 545 : 53 - 62
  • [12] TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity
    Johnson, Brian S.
    Snead, David
    Lee, Jonathan J.
    McCaffery, J. Michael
    Shorter, James
    Gitler, Aaron D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (30) : 20329 - 20339
  • [13] TDP-43 derived α-helical peptides: A novel strategy to prevent TDP-43 aggregation in neurodegenerative disorders
    Salaikumaran, Muthu Raj
    Gopal, Pallavi P.
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 169A - 169A
  • [14] Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
    Ducharme, Simon
    Pijnenburg, Yolande
    Rohrer, Jonathan D.
    Huey, Edward
    Finger, Elizabeth
    Tatton, Nadine
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (01): : 98 - 113
  • [15] TDP-43 as a potential retinal biomarker for neurodegenerative diseases
    Glashutter, Margit
    Wijesinghe, Printha
    Matsubara, Joanne A.
    FRONTIERS IN NEUROSCIENCE, 2025, 19
  • [16] TDP-43: an emerging new player in neurodegenerative diseases
    Wang, I-Fan
    Wu, Lien-Szu
    Shen, C-K. James
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (11) : 479 - 485
  • [17] Targeting TDP-43 in Mitochondria to Treat Neurodegenerative Diseases
    Wang, Xinglong
    Wang, Luwen
    Gao, Ju
    Siedlak, Sandra L.
    MOLECULAR THERAPY, 2017, 25 (05) : 111 - 111
  • [18] Decoding TDP-43: the molecular chameleon of neurodegenerative diseases
    Jixiang Zeng
    Chunmei Luo
    Yang Jiang
    Tao Hu
    Bixia Lin
    Yuanfang Xie
    Jiao Lan
    Jifei Miao
    Acta Neuropathologica Communications, 12 (1)
  • [19] Targeting TDP-43 in mitochondria to treat neurodegenerative diseases
    Wang, X.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 11 - 11
  • [20] TDP-43 proteinopathies: a new wave of neurodegenerative diseases
    de Boer, Eva Maria Johanna
    Orie, Viyanti K.
    Williams, Timothy
    Baker, Mark R.
    De Oliveira, Hugo M.
    Polvikoski, Tuomo
    Silsby, Matthew
    Menon, Parvathi
    van den Bos, Mehdi
    Halliday, Glenda M.
    van den Berg, Leonard H.
    Van den Bosch, Ludo
    van Damme, Philip
    Kiernan, Matthew
    van Es, Michael A.
    Vucic, Steve
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (01): : 86 - 95